Mon 5/25/2020 17:36 ET
S&P 5002955.457.090.24%BANKS310.942.710.87%OIL33.700.451.34%BITCOIN8920.75161.471.81%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Sorrento Therapeutics, Inc - SRNE)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SRNE
From: crainiac (Rep: 4191)Date: 04/02/2020 12:23
Forum: Wall Street Pit - Msg #2831079 - List SRNE msgs Thread #674139584 (Rec: 0)
The real breakthrough for the company, and one of the reasons why it’s attracted so much capital, is that its cell therapies don’t need to be cultivated from a patient donor — a lengthy and expensive process. Celularity is able to produce NK cells and store them, so that they can be ready for transfusion when they’re needed.

With the the FDA’s clearance, Celularity is going to begin a small, 86-person trial to test the efficacy of its CYNK-001 immunotherapy to treat COVID-19 infected adults, the company said.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreSRNE: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SRNE | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.